KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 124 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $3,000 | -40.0% | 1,010 | -30.3% | 0.00% | – |
| Q2 2018 | $5,000 | -16.7% | 1,450 | 0.0% | 0.00% | – |
| Q1 2018 | $6,000 | -14.3% | 1,450 | -9.4% | 0.00% | – |
| Q4 2017 | $7,000 | -93.5% | 1,600 | -89.4% | 0.00% | -100.0% |
| Q3 2017 | $107,000 | +791.7% | 15,100 | +843.8% | 0.00% | – |
| Q2 2017 | $12,000 | +50.0% | 1,600 | +23.1% | 0.00% | – |
| Q1 2017 | $8,000 | -11.1% | 1,300 | -18.8% | 0.00% | – |
| Q4 2016 | $9,000 | -30.8% | 1,600 | -36.0% | 0.00% | – |
| Q3 2016 | $13,000 | -23.5% | 2,500 | 0.0% | 0.00% | – |
| Q2 2016 | $17,000 | +54.5% | 2,500 | +4.2% | 0.00% | – |
| Q1 2016 | $11,000 | – | 2,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
| Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
| Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
| Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
| NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
| LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
| Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
| Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
| Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |